G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? K Sriram, PA Insel Molecular pharmacology 93 (4), 251-258, 2018 | 1303 | 2018 |
Vena caval filters for the prevention of pulmonary embolism T Young, KB Sriram Cochrane Database of Systematic Reviews, 2020 | 262 | 2020 |
A hypothesis for pathobiology and treatment of COVID‐19: the centrality of ACE1/ACE2 imbalance K Sriram, PA Insel British journal of pharmacology 177 (21), 4825-4844, 2020 | 229 | 2020 |
GPCRomics: an approach to discover GPCR drug targets PA Insel, K Sriram, MW Gorr, SZ Wiley, A Michkov, C Salmerón, AM Chinn Trends in pharmacological sciences 40 (6), 378-387, 2019 | 178 | 2019 |
Risks of ACE inhibitor and ARB usage in COVID‐19: evaluating the evidence K Sriram, PA Insel Clinical Pharmacology & Therapeutics 108 (2), 236-241, 2020 | 156 | 2020 |
GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets PA Insel, K Sriram, SZ Wiley, A Wilderman, T Katakia, T McCann, ... Frontiers in pharmacology 9, 431, 2018 | 127 | 2018 |
The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: A meta-analysis D Cannon, N Buys, KB Sriram, S Sharma, N Morris, J Sun Respiratory medicine 121, 81-90, 2016 | 119 | 2016 |
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer IA Yang, V Relan, CM Wright, MR Davidson, KB Sriram, ... Expert opinion on therapeutic targets 15 (4), 439-456, 2011 | 117 | 2011 |
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets K Sriram, PA Insel Physiological reviews 101 (2), 545-567, 2021 | 113 | 2021 |
GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells SZ Wiley, K Sriram, W Liang, SE Chang, R French, T McCann, J Sicklick, ... The FASEB Journal 32 (3), 1170, 2018 | 100 | 2018 |
GPR68: an emerging drug target in cancer SZ Wiley, K Sriram, C Salmerón, PA Insel International journal of molecular sciences 20 (3), 559, 2019 | 95 | 2019 |
Diagnostic molecular biomarkers for malignant pleural effusions KB Sriram, V Relan, BE Clarke, EE Duhig, IA Yang, RV Bowman, ... Future Oncology 7 (6), 737-752, 2011 | 87 | 2011 |
Tuberculosis infection of the breast mistaken for granulomatous mastitis: a case report KB Sriram, D Moffatt, R Stapledon Cases Journal 1, 1-4, 2008 | 77 | 2008 |
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas KB Sriram, V Relan, BE Clarke, EE Duhig, MN Windsor, KS Matar, ... BMC cancer 12, 1-12, 2012 | 75 | 2012 |
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors K Sriram, K Moyung, R Corriden, H Carter, PA Insel PLoS biology 17 (11), e3000434, 2019 | 73 | 2019 |
Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients KB Sriram, M Percival Chronic respiratory disease 13 (1), 13-22, 2016 | 72 | 2016 |
Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease P Kumar, S Law, KB Sriram Journal of thoracic disease 9 (6), 1509, 2017 | 68 | 2017 |
Whole genome sequencing for lung cancer M Daniels, F Goh, CM Wright, KB Sriram, V Relan, BE Clarke, EE Duhig, ... Journal of thoracic disease 4 (2), 155, 2012 | 61 | 2012 |
Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians KB Sriram, AJ Cox, RL Clancy, MPE Slack, AW Cripps Critical Reviews in Microbiology 44 (2), 125-142, 2018 | 53 | 2018 |
Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer KB Sriram, ME Tan, SM Savarimuthu, CM Wright, V Relan, RE Stockwell, ... European Respiratory Journal 38 (4), 903-910, 2011 | 39 | 2011 |